Urinary podocytes for the assessment of disease activity in lupus nephritis

American Journal of the Medical Sciences

Volumn 320, Issue 2, 2000, Pages 112-116

  Nakamura, Tsukasa ^a   Ushiyama, Chifuyu ^a   Suzuki, Shingo ^a   Hara, Masanori ^b   Shimada, Noriaki ^c   Sekizuka, Keiko ^c   Ebihara, Isao ^c   Koide, Hikaru ^c  

^a Misato Junshin Hospital   (Japan)

^b Yoshida Hospital   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

Corticosteroid; Podocalyxin; Renal failure; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PODOCALYXIN; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PODOCYTE; PROTEINURIA; STEROID THERAPY; URINALYSIS;

EID: 0033838355     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200008000-00009     Document Type: Article

References (15)

1. Comparative value of urinalysis, urine cytology and urine soluble IL-2R in the assessment of renal disease in patients with SLE
2. Lupus as a renal disease
3. Eicosanoid synthesis in peripheral blood monocytes: A marker of disease activity in lupus nephritis
4. The role of podocytes in the development of glomerular sclerosis
5. How does glomerular epithelial cell injury contribute to progressive glomerular damage?
6. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis
7. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis
8. The 1982 revised criteria for the classification of systemic lupus erythematosus
9. Urinary detected renal antigens in the early diagnosis of kidney graft rejection
10. Urinary excretion of brush-border antigen revealed by monoclonal antibody: Early indicator of toxic nephropathy
11. Renal platelet-derived growth factor gene expression in NZB/W F1 mice with lupus and ddY mice with IgA nephropathy
12. Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice
13. Clinical biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis
14. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis
15. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis